Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
05.11.25
/
50%
€268.25
Target price
05.11.26
€348.04
Performance (%)
31.45%
Price
28.07.26
€345.20
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Amgen Inc. has seen massive gains of 31.45%. Dividends of €7.42 are taken into consideration when calculating the performance. This prediction currently runs until 05.11.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 7.489% | 7.489% |
| iShares Core DAX® | 1,72 % | 3,37 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % |
| iShares S&P 500 | -0,89 % | 1,69 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $405.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat